483 Roundup: FDA Cites Italian, Indian and Chinese Firms By Sam | January 17, 2018 The FDA flagged facilities in Italy, India and China for noncompliances including inadequate testing, complaint handling, and quality data, among other violations. Source: Drug GMP Report Posted in Drug GMP Report